TrialAntimicrobial agents and chemotherapy2007

Safety and pharmacokinetics of Bevirimat (PA-457), a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteers.

David E Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.